Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: A validation study combining metaphase and interphase analyses

American Journal of Clinical Pathology

Volumn 133, Issue 1, 2010, Pages 116-126

  Brunelli, Matteo ^a   Delahunt, Brett ^b   Gobbo, Stefano ^a   Tardanico, Regina ^c   Eccher, Albino ^a   Bersani, Samantha ^a   Cossu Rocca, Paolo ^d   Parolini, Claudia ^a   Balzarini, Piera ^c   Menestrina, Fabio ^a   Cheng, Liang ^e   Eble, John Nelson ^e   Martignoni, Guido ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c Spedali Civili   (Italy)

^d UNIVERSITY OF SASSARI   (Italy)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chromophobe renal carcinoma; Interphase fluorescence in situ hybridization; Metaphase karyotyping; Oncocytoma

Indexed keywords

ARTICLE; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERPHASE; KARYOTYPING; KIDNEY CARCINOMA; KIDNEY ONCOCYTOMA; METAPHASE; ONCOCYTOMA; POLYPLOIDY; PRIORITY JOURNAL;

ADENOMA, OXYPHILIC; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; KIDNEY NEOPLASMS; METAPHASE; TISSUE ARRAY ANALYSIS;

EID: 73949099388     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPSATJTKBI6J4N     Document Type: Article

References (45)

1. Martignoni G, Pea M, Chilosi M, et al. Parvalbumin is constantly expressed in chromophobe renal carcinoma. Mod Pathol. 2001;14:760-767.
2. Martignoni G, Pea M, Brunelli M, et al. CD10 is expressed in a subset of chromophobe renal cell carcinomas. Mod Pathol. 2004;17:1455-1463.
3. Storkel S, Martignoni G, van den Berg E. Chromophobe renal cell carcinoma. In: Eble JN, Sauter G, Epstein JI, et al, eds. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004:30-32. World Health Organization Classification of Tumours.
4. Brunelli M, Gobbo S, Cossu-Rocca P, et al. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod Pathol. 2007;20:303-309.
5. Martignoni G, Tardanico R, Pea M, et al. Renal tumours. In: Mikuz G, ed. Clinical Pathology of Urologic Tumors. London, England: Informa Healthcare; 2007:1-41.
6. Young AN, Amin MB, Moreno CS, et al. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol. 2001;158:1639-1651.
7. Martignoni G, Brunelli M, Gobbo S, et al. Role of molecular markers in diagnosis and prognosis of renal cell carcinoma. Anal Quant Cytol Histol. 2007;29:41-49.
8. Brunelli M, Eble JN, Zhang S, et al. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma. Mod Pathol. 2005;18:161-169.
9. Kovacs A, Kovacs G. Low chromosome number in chromophobe renal cell carcinomas. Genes Chromosomes Cancer. 1992;4:267-268.
10. Brunelli M, Gobbo S, Cossu-Rocca P, et al. Fluorescence cytogenetics of renal cell neoplasms. Pathologica. 2008;100:455-461.
11. Gunawan B, Bergmann F, Braun S, et al. Polyploidization and losses of chromosomes 1, 2, 6, 10, 13, and 17 in three cases of chromophobe renal cell carcinomas. Cancer Genet Cytogenet. 1999;110:57-61.
12. Verdorfer I, Hobisch A, Hittmair A, et al. Cytogenetic characterization of 22 human renal cell tumors in relation to a histopathological classification. Cancer Genet Cytogenet. 1999;111:61-70.
13. Lindgren V, Paner GP, Omeroglu A, et al. Cytogenetic analysis of a series of 13 renal oncocytomas. J Urol. 2004;171:602-604.
14. Paner GP, Lindgren V, Jacobson K, et al. High incidence of chromosome 1 abnormalities in a series of 27 renal oncocytomas: cytogenetic and fluorescence in situ hybridization studies. Arch Pathol Lab Med. 2007;131:81-85.
15. Fuzesi L, Frank D, Nguyen C, et al. Losses of 1p and chromosome 14 in renal oncocytomas. Cancer Genet Cytogenet. 2005;160:120-125.
16. Akhtar M, Chantziantoniou N. Flow cytometric and quantitative image cell analysis of DNA ploidy in renal chromophobe cell carcinoma. Hum Pathol. 1998;29:1181-1188.
17. Amin MB, Paner GP, Alvarado-Cabrero I, et al. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol. 2008;32:1822-1834.
18. Rocca PC, Brunelli M, Gobbo S, et al. Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study. Mod Pathol. 2007;20:722-728.
19. Limon J, Dal Cin P, Sandberg AA. Application of longterm collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet. 1986;23:305-313.
20. Brunelli M, Delahunt B, Ficarra V, et al. Utility of tissue microarrays for assessment of chromosomal abnormalities in chromophobe renal cell carcinoma. Anal Quant Cytol Histol. 2009. In press.
21. Kovacs G. The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours. World J Urol. 1994;12:64-68.
22. Hoglund M, Gisselsson D, Mandahl N, et al. Multivariate analyses of genomic imbalances in solid tumors reveal distinct and converging pathways of karyotypic evolution. Genes Chromosomes Cancer. 2001;31:156-171.
23. Hoglund M, Gisselsson D, Soller M, et al. Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data. Cancer Genet Cytogenet. 2004;153:1-9.
24. Elfving P, Aman P, Mandahl N, et al. Trisomy 7 in nonneoplastic epithelial kidney cells. Cytogenet Cell Genet. 1995;69:90-96.
25. Elfving P, Mandahl N, Lundgren R, et al. Prognostic implications of cytogenetic findings in kidney cancer. Br J Urol. 1997;80:698-706.
26. Limon J, Mrozek K, Heim S, et al. On the significance of trisomy 7 and sex chromosome loss in renal cell carcinoma. Cancer Genet Cytogenet. 1990;49:259-263.
27. Jones TD, Eble JN, Cheng L. Application of molecular diagnostic techniques to renal epithelial neoplasms. Clin Lab Med. 2005;25:279-303.
28. Cossu-Rocca P, Eble JN, Delahunt B, et al. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol. 2006;19:488-493.
29. Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol. 2008;32:1239-1245.
30. Gobbo S, Eble JN, Maclennan GT, et al. Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis. Am J Surg Pathol. 2008;32:1780-1786.
31. Brunelli M, Eble JN, Zhang S, et al. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma. Mod Pathol. 2003;16:1060-1063.
32. Picken MM, Chyna B, Flanigan RC, et al. Analysis of chromosome 1p abnormalities in renal oncocytomas by loss of heterozygosity studies: correlation with conventional cytogenetics and fluorescence in situ hybridization. Am J Clin Pathol. 2008;129:377-382.
33. Nagy A, Buzogany I, Kovacs G. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes. Histopathology. 2004;44:542-546.
34. Presti JC Jr, Moch H, Reuter VE, et al. Comparative genomic hybridization for genetic analysis of renal oncocytomas. Genes Chromosomes Cancer. 1996;17:199-204.
35. Zanssen S, Gunawan B, Fuzesi L, et al. Renal oncocytomas with rearrangements involving 11q13 contain breakpoints near CCND1. Cancer Genet Cytogenet. 2004;149:120-124.
36. Jhang JS, Narayan G, Murty VV, et al. Renal oncocytomas with 11q13 rearrangements: cytogenetic, molecular, and immunohistochemical analysis of cyclin D1. Cancer Genet Cytogenet. 2004;149:114-119.
37. Bugert P, Gaul C, Weber K, et al. Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab Invest. 1997;76:203-208.
38. Hes O, Vanecek T, Perez-Montiel DM, et al. Chromophobe renal cell carcinoma with microcystic and adenomatous arrangement and pigmentation: a diagnostic pitfall: morphological, immunohistochemical, ultrastructural and molecular genetic report of 20 cases. Virchows Arch. 2005;446:383-393.
39. Moch H, Sauter G, Gasser TC, et al. EGF-r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization. J Pathol. 1998;184:424-429.
40. Akhtar M, Chantziantoniou N. Quantitative image cell analysis of cytologic smears for DNA ploidy in renal parenchymal neoplasms. Diagn Cytopathol. 1999;21:223-229.
41. Gisselsson D, Gorunova L, Hoglund M, et al. Telomere shortening and mitotic dysfunction generate cytogenetic heterogeneity in a subgroup of renal cell carcinomas. Br J Cancer. 2004;91:327-332.
42. Gisselsson D, Hoglund M. Connecting mitotic instability and chromosome aberrations in cancer: can telomeres bridge the gap? Semin Cancer Biol. 2005;15:13-23.
43. Gisselsson D, Jonson T, Petersen A, et al. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci U S A. 2001;98:12683-12688.
44. Gisselsson D. Chromosome instability in cancer: how, when, and why? Adv Cancer Res. 2003;87:1-29.
45. Russo P, Goetzl M, Simmons R, et al. Partial nephrectomy: the rationale for expanding the indications. Ann Surg Oncol. 2002;9:680-687.